Long-Term Protection of Hepatitis B Vaccine: Lessons from Alaskan Experience after 15 Years
- 1 March 2005
- journal article
- Published by American College of Physicians in Annals of Internal Medicine
- Vol. 142 (5) , 384-385
- https://doi.org/10.7326/0003-4819-142-5-200503010-00014
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- 18-year follow-up study of a prospective randomized trial of hepatitis B vaccinations without booster doses in childrenClinical Gastroenterology and Hepatology, 2004
- Long‐Term Persistence of Immunity to Hepatitis B after Vaccination during Infancy in a Country Where Endemicity Is LowThe Journal of Infectious Diseases, 2004
- Hepatitis B Virus Infection — Natural History and Clinical ConsequencesNew England Journal of Medicine, 2004
- Long?Term Immunogenicity and Efficacy of Universal Hepatitis B Virus Vaccination in TaiwanThe Journal of Infectious Diseases, 2003
- Global control of hepatitis B virus infectionPublished by Elsevier ,2002
- Hepatitis B Virus Infection in Children and Adolescents in a Hyperendemic Area: 15 Years after Mass Hepatitis B VaccinationAnnals of Internal Medicine, 2001
- Universal hepatitis B vaccination and the decreased mortality from fulminant hepatitis in infants in TaiwanThe Journal of Pediatrics, 2001
- Lifelong protection against hepatitis B: the role of vaccine immunogenicity in immune memoryVaccine, 2000
- Elimination of New Chronic Hepatitis B Virus Infections: Results of the Alaska Immunization ProgramThe Journal of Infectious Diseases, 2000
- Long-term efficacy of plasma-derived hepatitis B vaccine: a 15-year follow-up study among Chinese childrenVaccine, 1999